Upper airway microbiome and clinical outcomes in bronchiectasis: the EMBARC-BRIDGE study
作者
Hayoung Choi,Hollian Richardson,Chandani Kumari HENNAYAKE,Morven K. Shuttleworth,Arietta Spinou,Kara Robertson,Merete Bridget Long,Anthony De Soyza,Felix C. Ringshausen,Pieter Goeminne,Natalie Lorent,CHARLES S. HAWORTH,Josje Altenburg,Michael R. Loebinger,Mathieu Bottier,Daniela Alferes De Lima Headley,Erin Cant,Alison Dicker,Francesco Blasi,Michal Shteinberg
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2025-09-27卷期号:: PA3952-PA3952被引量:1
标识
DOI:10.1183/13993003.congress-2025.pa3952
摘要
Introduction: Previous research has identified microbiome profiles relevant to bronchiectasis outcomes; however, few studies have characterised the upper airway microbiome. We aimed to evaluate the relationship between the upper airway microbiome and clinical outcomes in bronchiectasis. Methods: Nasopharyngeal swabs were collected from 344 bronchiectasis patients enrolled across five European centres at baseline as part of the EMBARC-BRIDGE study ( NCT03791086 ). 104 patients also had 1-year follow-up nasal swab samples at the time of analysis. The microbiome composition (16S rRNA sequencing) was analysed based on the BSI groups and severe exacerbations in the past year. The α and β diversity were measured using the Shannon–Wiener and Bray-Curtis index, respectively, and random forest analysis was performed. Results: Of the 344 patients, 200 (58.1%) were females, with a median age of 68 (interquartile range, 59–75) years. Although α-diversity was not significantly different across groups, β-diversity analysis revealed distinct microbiome profiles associated with disease severity and severe exacerbation (PERMANOVA P=0.021 and 0.001, respectively). In random forest analysis, severe disease was associated with increased Pseudomonas, and reduced relative abundance of Actinomyces, Cutibacterium and Anaerococcus; severe exacerbation was also related to increased Pseudomonas, and reduced relative abundance of Corynebacterium, Anaerococcus and Peptoniphilus. In a longitudinal analysis, the microbiome profiles were relatively stable between baseline and 1-year follow-up (PERMANOVA P=0.21). Conclusion: The upper airway microbiome is associated with disease severity and severe exacerbation in bronchiectasis.